IRTC Stock Overview
A digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
iRhythm Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$90.59 |
| 52 Week High | US$126.12 |
| 52 Week Low | US$70.24 |
| Beta | 1.31 |
| 1 Month Change | -20.27% |
| 3 Month Change | -21.27% |
| 1 Year Change | -26.95% |
| 3 Year Change | 22.19% |
| 5 Year Change | 35.01% |
| Change since IPO | 247.75% |
Recent News & Updates
Recent updates
iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt
May 13
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't
Mar 25Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results
Feb 25iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?
Feb 02iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate
Dec 20iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable
Dec 20Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Dec 02Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?
Sep 20iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate
Aug 30When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Jul 04Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?
Jun 16Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)
May 26iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark
May 08What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?
Mar 27Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?
Feb 25Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?
Nov 24iRhythm falls after reaffirming 2022 guidance
Sep 21iRhythm: Fairly Priced At Current Multiples, No Need To Size Up
Sep 02Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?
Aug 18iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance
Aug 04iRhythm Technologies provides FY22 prelims, commercial chief resigns
Jul 19iRhythm: Reimbursement Overhang Squashed, Bull Thesis Back Intact
Jun 08Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?
Apr 14Shareholder Returns
| IRTC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -9.9% | -0.2% | -0.2% |
| 1Y | -26.9% | 5.2% | 28.2% |
Return vs Industry: IRTC underperformed the US Medical Equipment industry which returned 4.2% over the past year.
Return vs Market: IRTC underperformed the US Market which returned 27.7% over the past year.
Price Volatility
| IRTC volatility | |
|---|---|
| IRTC Average Weekly Movement | 7.2% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: IRTC's share price has been volatile over the past 3 months.
Volatility Over Time: IRTC's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,000 | Quentin Blackford | www.irhythmtech.com |
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period.
iRhythm Technologies, Inc. Fundamentals Summary
| IRTC fundamental statistics | |
|---|---|
| Market cap | US$2.85b |
| Earnings (TTM) | -US$129.96m |
| Revenue (TTM) | US$513.17m |
5.5x
P/S Ratio-21.7x
P/E RatioIs IRTC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IRTC income statement (TTM) | |
|---|---|
| Revenue | US$513.17m |
| Cost of Revenue | US$169.53m |
| Gross Profit | US$343.64m |
| Other Expenses | US$473.61m |
| Earnings | -US$129.96m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.18 |
| Gross Margin | 66.96% |
| Net Profit Margin | -25.33% |
| Debt/Equity Ratio | 713.3% |
How did IRTC perform over the long term?
See historical performance and comparison